Hideaki Kato

Dr. Hideaki Kato

Yokohama City University Hospital, Yokohama, Kanagawa, Japan
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MIMasaki Imai
Masaki Imai
PHPeter J. Halfmann
Peter J. Halfmann
Seiya YamayoshiSeiya Yamayoshi
Seiya Yamayoshi
KIKiyoko Iwatsuki-Horimoto
Kiyoko Iwatsuki-Horimoto
SCShiho Chiba
Shiho Chiba
YKYoshihiro Kawaoka
Yoshihiro Kawaoka
Significance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are of concern, with the P.1 variants dominating in Brazil. Brazil is now seeing a record number of deaths. Here, we report that the pathogenicity in hamsters of a P.1 variant is similar to that of nonvariant SARS-CoV-2. However, it has an expanded host range as shown by its replication in mice. Prior infection with nonvariant SARS-CoV-2 strains efficiently prevented replication of the P.1 variant in the lower respiratory tract of hamsters upon reinfection. Convalescent sera from patients infected with nonvariants or sera from messenger RNA vaccinees showed comparable neutralization titers among the P.1 and previously circulating strains. These results suggest that previous SARS-CoV-2 infection and vaccines based on the original SARS-CoV-2 will provide some protection against P.1 infection.

1 May 2019 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
HKHideaki Kato
Hideaki Kato
YYYukihiro Yoshimura
Yukihiro Yoshimura
YSYoshihiro Suido
Yoshihiro Suido
HSHiroyuki Shimizu
Hiroyuki Shimizu
KIKazuo Ide
Kazuo Ide
HNHideaki Nakajima
Hideaki Nakajima

29 June 2018 in Infection
Verified
Journal Article
Closed access
PDF file
HKHideaki Kato
Hideaki Kato
YYYukihiro Yoshimura
Yukihiro Yoshimura
YSYoshihiro Suido
Yoshihiro Suido
KIKazuo Ide
Kazuo Ide
YSYoshifumi Sugiyama
Yoshifumi Sugiyama
HNHideaki Nakajima
Hideaki Nakajima

1 August 2020 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
HKHideaki Kato
Hideaki Kato
HSHiroyuki Shimizu
Hiroyuki Shimizu
YSYasushi Shibue
Yasushi Shibue
THTomohiro Hosoda
Tomohiro Hosoda
KIKeisuke Iwabuchi
Keisuke Iwabuchi
HNHideaki Nakajima
Hideaki Nakajima

13 April 2022 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
KOKeisuke Oka
Keisuke Oka
AMAkane Matsumoto
Akane Matsumoto
NTNobuyuki Tetsuka
Nobuyuki Tetsuka
HMHiroshi Morioka
Hiroshi Morioka
MIMitsutaka Iguchi
Mitsutaka Iguchi
TYTetsuya Yagi
Tetsuya Yagi
The dissemination of difficult-to-treat carbapenem-resistant Enterobacterales (CRE) is of great concern. We clarified the risk factors underlying CRE infection mortality in Japan. We conducted a retrospective, multicentre, observational cohort study of patients with CRE infections at 28 university hospitals from September 2014 to December 2016, using the Japanese National Surveillance criteria. Clinical information, including patient background, type of infection, antibiotic treatment, and treatment outcome, was collected. The carbapenemase genotype was determined using PCR sequencing. Multivariate analysis was performed to identify the risk factors for 28-day mortality. Among the 179 patients enrolled, 65 patients (36.3%) had bloodstream infections, with 37 (20.7%) infections occurring due to carbapenemase-producing Enterobacterales (CPE); all carbapenemases were of IMP-type (IMP-1: 32, IMP-6: 5). Two-thirds of CPE were identified as Enterobacter cloacae complex. Combination therapy was administered only in 46 patients (25.7%), and the 28-day mortality rate was 14.3%. Univariate analysis showed that solid metastatic cancer, Charlson Comorbidity Index ≥3, bloodstream infection, pneumonia, or empyema, central venous catheters, mechanical ventilation, and prior use of quinolones were significant risk factors for mortality. Multivariate analysis revealed that mechanical ventilation (OR: 6.71 [1.42-31.6], P = 0.016), solid metastatic cancers (OR: 5.63 [1.38-23.0], P = 0.016), and bloodstream infections (OR: 3.49 [1.02-12.0], P = 0.046) were independent risk factors for 28-day mortality. The significant risk factors for 28-day mortality in patients with CRE infections in Japan are mechanical ventilation, solid metastatic cancers, and bloodstream infections.